Janet Qi is the co-founder and CEO of Pureminds NeuroPharma, a drug development company focused on treating neurological disorders using psychedelic and small molecule clinical programs. Pureminds NeuroPharma holds a Health Canada approved drug license for controlled substances, allowing them to produce, sell, import, and export psychedelic compounds.